U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.

Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.

The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.


If you or a loved one test positive for COVID-19 or are at high risk for serious COVID-19 and have been recently exposed to someone who tested positive for COVID-19, you may now have treatment options. COVID-19 treatment options are available for patients with mild to moderate symptoms, patients in the hospital, and people who may not have symptoms but have been exposed to someone who has tested positive for COVID-19 and are high risk for serious COVID-19.

The U.S. Food and Drug Administration (FDA) has authorized treatments for emergency use. Talk to your healthcare professional about treatment options. Your healthcare professional will know the best option for you based on your symptoms and your health history. If you do not have a healthcare professional, call 1-877-332-6585 to find out who to talk with about your symptoms and treatment.



The following treatments have been authorized for emergency use by the FDA for patients who are not in the hospital and with mild to moderate cases of COVID-19. The FDA has determined that the known and potential benefits of these treatments for patients not in the hospital are greater than the treatments' known and potential risks.

Monoclonal antibody (mAb) treatments: The FDA has issued Emergency Use Authorization (EUA) for four investigational mAb treatments that can attach to SARS-CoV-2, the coronavirus that causes COVID-19. These antibodies could help your immune system recognize and respond more effectively to the virus.

Three of these treatments have been authorized for patients with mild to moderate cases. This includes those who have had symptoms for 10 days or less, who are 12 years of age and older, and who are at high risk for progressing to serious COVID-19 and are not in the hospital. It also includes people who are 65 years or older and people who have certain chronic medical conditions. People who are at high risk for serious COVID-19 and have been exposed to someone who has tested positive for COVID-19 may be eligible for mAb prophylactic treatment. You do not have to test positive or have symptoms to be able to get mAb prophylactic treatment. Learn more about antibody treatments with: bamlanivimab and etesevimab, casirivimab and imdevimab (REGEN-COV), and sotrovimab

Actemra (tocilizumab) is an additional mAb treatment that has been issued an EUA for the treatment of adult and pediatric patients (≥ 2 years of age) in the hospital. 

There is no cost for the antibodies themselves, but the facility may charge for the infusion (giving the treatment by IV). Medicare covers the IV treatment costs, but Medicaid coverage is different in each state. Many large private insurance plans cover all costs, but you should check with yours to find out for sure. If you do not have insurance, ask the treatment facility if there are any fees.

Learn what mAbs are and how they can help


The following treatments for patients in the hospital with worsening (serious) cases of COVID-19 have been approved or authorized for emergency use by the FDA.

Remdesivir: This is the first drug approved by the FDA for the treatment of COVID-19 in adults and pediatric patients at least 12 years of age in the hospital. Remdesivir, also known as Veklury®, is in a class of treatments called antivirals. It works by stopping SARS-CoV-2 from spreading in the body.

Actemra (tocilizumab): This is a mAb authorized for emergency use for the treatment of some patients in the hospital with COVID-19. Actemra is a medication that is FDA-approved for multiple inflammatory diseases, including rheumatoid arthritis, and has shown in studies that it may be effective in treating COVID-19.

Other available COVID-19 treatments: Other drugs and treatments (such as mAbs, described above) are used to slow or reduce the virus’ growth and spread in the body, as well as to enhance breathing and help with other symptoms.

Treatment options for patients in the hospital with COVID-19 chart


Because the coronavirus that causes COVID-19 is a novel or new virus, we are still learning about it. Hundreds of clinical studies (also known as clinical trials) for COVID-19 treatments are happening now, and many other clinical trials are looking for participants.

The participation of patients with COVID-19 in clinical trials is critical to finding effective treatments. It is also important for people from all backgrounds to participate. Researchers need to test treatments and vaccines in all populations, including Black/African American, Hispanic/Latino, and Native American communities, to be sure the treatments and vaccines work in all people affected by COVID-19.

Find a clinical trial

Doctor recording notes on a clipboard